St. Louis Park, Minnesota Clinical Trials

A listing of St. Louis Park, Minnesota clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 58 clinical trials
The Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Vaccination

Hypothesis: Infections other than HIV can cause LN inflammation and collagen damage to the fibroblastic reticular cell network (FRCn), which will lead to CD4 T cell depletion and impaired vaccine responses. This protocol will study yellow fever vaccine (YFV) in two cohorts of people, one from Uganda and the other …

vaccination
immunosuppressive
yellow fever
University of Minnesota
 (6.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Subjects with Neurofibromatosis Type 2 (NF2) and progressive vestibular schwannoma (VS) will be treated with crizotinib administered orally. Crizotinib will be taken continuously until disease progression or unacceptable toxicity, in continuous treatment cycles of 28 days each, for a maximum of 12 cycles.

schwartz
glioma
neutrophil count
nf2 gene
crizotinib
Mayo Clinic (Site 908)
 (5.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +16 other locations
Test CPR 2  

Test CPR 2

Site with Site User
 (4.2 away)
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
None

HealthPartners Institute
 (1.6 away) Contact site
  • 0 views
  • 19 May, 2025
  • +12 other locations
None

HealthPartners Institute
 (1.6 away) Contact site
  • 0 views
  • 19 May, 2025
  • +13 other locations
Partial-enteral Nutrition Protocol for Crohn's Disease

A novel dietary intervention combining a standardized IBD diet (IBD-AID) with supplementation from a pea protein plant-based oral nutrition supplement (ONS) (Kate Farms Peptide 1.5) to improve protein, calorie, and nutrient intake in adult patients experiencing a Crohn's disease flare starting new immunologic therapy. Additionally, this study will include objective …

University of Minnesota
 (6.7 away) Contact site
  • 0 views
  • 13 Aug, 2025
  • 1 location
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to three dose levels in adult participants aged 18 to 45 years with moderate to severe acne. This trial will consist of a …

Clinical Research Institute- Site Number : 8400080
 (5.0 away) Contact site
  • 0 views
  • 29 Nov, 2025
  • +30 other locations
Identification of Predictors for Clinical Outcomes in Femoroacetabular Impingement Surgery

The overarching goal of the study is to improve the surgical treatment outcomes of FAI, which is affecting an increasing number of military personnel and young active individuals in the general population. The proposed study will investigate critical patient, disease, and surgical treatment predictors of FAI surgery outcomes.

conservative management
hip arthroscopy
arthroscopy
femoroacetabular impingement
Twin Cities Orthopedics
 (6.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +11 other locations
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

deficiency
eliglustat
imiglucerase
gaucher disease
Investigational Site Number 840046
 (5.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +220 other locations
Mucopolysaccharidosis I (MPS I) Registry

The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients …

Investigational Site Number 840114
 (5.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +135 other locations